-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Downgrades Fractyl Health to Equal-Weight, Lowers Price Target to $2

Benzinga·01/30/2026 17:11:28
Listen to the news
Morgan Stanley analyst Michael Ulz downgrades Fractyl Health (NASDAQ:GUTS) from Overweight to Equal-Weight and lowers the price target from $8 to $2.